Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Welcia Holdings Co's Debt-to-EBITDA or its related term are showing as below:
WLCGF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.64 Med: 0.97 Max: 1.52
Current: 1.2
During the past 13 years, the highest Debt-to-EBITDA Ratio of Welcia Holdings Co was 1.52. The lowest was 0.64. And the median was 0.97.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Welcia Holdings Co Debt-to-EBITDA Related Terms
Welcia Holdings Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Welcia Holdings Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welcia Holdings Co Debt-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Welcia Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welcia Holdings Co Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Welcia Holdings Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Welcia Holdings Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Aug. 2025) EBITDA data.
Welcia Holdings Co (WLCGF) has a Debt-to-EBITDA of 0.60 as of Aug. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Welcia Holdings Co. This is 38% below median its historical median of 0.97. Over the past decade, Welcia Holdings Co's Debt-to-EBITDA has ranged from 0.64 to 1.52.
Is Welcia Holdings Co's Debt-to-EBITDA too high?
Welcia Holdings Co's current Debt-to-EBITDA of 0.60 is 38% below median its 10-year median of 0.97. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 1.52. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.22. Welcia Holdings Co's value of 0.60 is 73% below this industry median. Overall, Welcia Holdings Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Welcia Holdings Co's Debt-to-EBITDA compare to competitors?
Welcia Holdings Co's Debt-to-EBITDA of 0.60 can be compared against companies in the Healthcare Providers & Services industry. The industry median Debt-to-EBITDA is 2.22. Welcia Holdings Co's value of 0.60 is 73% below this benchmark. Historically, Welcia Holdings Co's own Debt-to-EBITDA has ranged from 0.64 to 1.52 over the past decade. While the company's 10-year median is 0.97 vs. the industry median of 2.22, Welcia Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Welcia Holdings Co's current Debt-to-EBITDA of 0.60 is 73% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Welcia Holdings Co. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welcia Holdings Co's current Debt-to-EBITDA is 0.60, which is 38% below median its own 10-year median of 0.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcia Holdings Co stock overvalued right now?
Welcia Holdings Co (WLCGF) has a current Debt-to-EBITDA of 0.60. The stock's GF Value™ is $14.20, compared to a current price of $16.41 — trading 15.6% above its estimated fair value. The current Debt-to-EBITDA is 0.60, which is 38% below median its 10-year median of 0.97 and 73% below the Healthcare Providers & Services industry median of 2.22. Welcia Holdings Co's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Welcia Holdings Co (WLCGF), the current Debt-to-EBITDA is 0.60 as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Welcia Holdings Co (WLCGF) Overvalued in 2026?
Based on GuruFocus' analysis, Welcia Holdings Co stock appears to be overvalued.
The current stock price of $16.41 is trading 15.6% above its estimated GF Value™ of $14.20.
Key valuation signals for WLCGF:
Debt-to-EBITDA: 0.60 (38% below median its 10-year median of 0.97)
GF Value™: $14.20 vs. price of $16.41 (15.6% above fair value)
Industry Position: 73% below the Healthcare Providers & Services median
No single metric tells the full story. See the WLCGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Welcia Holdings Co Ltd operates drug retail stores that sell pharmaceuticals, health and beauty products, baby supplies, health supplements, sanitation items, groceries, and personal-care products. The company generates the bulk of its revenue through sales of over-the-counter drugs and food products. Welcia is involved in pharmaceutical dispensing, blood testing, and earthquake reconstruction assistance. The highest concentration of sales remains in the Kanto region of Japan. Welcia also provides nursing services through its long-term care enterprise.
18GF Score
Get the complete analysis for WLCGF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WLCGF has been successfully added to your 
